Clinical Features and Outcomes of Acute Intermittent Porphyria Presenting With Acute Quadriparesis: A Case Series and Follow-Up Study. [PDF]
Alhammad RM +9 more
europepmc +1 more source
Porphobilinogen synthase: An equilibrium of different assemblies in human health
Eileen K. Jaffe
openalex +2 more sources
Baseline urinary ALA and PBG as criteria for starting pharmacologic prophylactic treatment in acute intermittent porphyria treated with givosiran. [PDF]
Kuo HC +5 more
europepmc +1 more source
Acute Intermittent Porphyria: A Diagnostic Conundrum. [PDF]
Vadivel VB, Lamba S.
europepmc +1 more source
Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates. [PDF]
Córdoba KM +29 more
europepmc +1 more source
Hepatoerythropoietic Porphyria with Coexisting <i>BTD</i> And <i>CNGB1</i> Genetic Mutations: A First Case Report. [PDF]
Kaya Ç +4 more
europepmc +1 more source
Presynaptic Neuromuscular Inhibition by Porphobilinogen and Porphobilin
Daniel S. Feldman +4 more
openalex +2 more sources
Acute Intermittent Porphyria in an Adolescent Patient: Diagnostic and Treatment Challenges. [PDF]
Rudnick SB +4 more
europepmc +1 more source
Features of Undiagnosed Abdominal Pain and Diagnostic Status of Acute Hepatic Porphyria in Japan: A Retrospective Study. [PDF]
Tago M +15 more
europepmc +1 more source

